LLY

965.5

+4.67%↑

JNJ

187.39

+0.59%↑

UNH

319.05

-1.56%↓

NVS

126.74

+0.36%↑

ABT

125.72

-0.37%↓

LLY

965.5

+4.67%↑

JNJ

187.39

+0.59%↑

UNH

319.05

-1.56%↓

NVS

126.74

+0.36%↑

ABT

125.72

-0.37%↓

LLY

965.5

+4.67%↑

JNJ

187.39

+0.59%↑

UNH

319.05

-1.56%↓

NVS

126.74

+0.36%↑

ABT

125.72

-0.37%↓

LLY

965.5

+4.67%↑

JNJ

187.39

+0.59%↑

UNH

319.05

-1.56%↓

NVS

126.74

+0.36%↑

ABT

125.72

-0.37%↓

LLY

965.5

+4.67%↑

JNJ

187.39

+0.59%↑

UNH

319.05

-1.56%↓

NVS

126.74

+0.36%↑

ABT

125.72

-0.37%↓

Search

Aytu BioScience Inc

Ouvert

2.03 0.5

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.96

Max

2.04

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+351.72% upside

Dividendes

By Dow Jones

Prochains Résultats

13 nov. 2025

Aytu BioScience Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 nov. 2025, 21:36 UTC

Résultats

Australia's ANZ Bank Posts 10% Drop in Annual Profit -- Update

9 nov. 2025, 21:22 UTC

Résultats

Australia's ANZ Bank Posts 10% Drop in Annual Profit

10 nov. 2025, 00:00 UTC

Market Talk

India Inflation Poised to Hit New Low -- Market Talk

9 nov. 2025, 23:47 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

9 nov. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Signs of U.S. Economic Weakness -- Market Talk

9 nov. 2025, 21:05 UTC

Résultats

ANZ FY Total Operating Expenses A$12.88B Vs. A$11.465B Pro Forma>ANZ.AU

9 nov. 2025, 21:04 UTC

Résultats

ANZ FY Operating Expenses A$11.85B Ex-Significant Items>ANZ.AU

9 nov. 2025, 21:03 UTC

Résultats

ANZ 2H Net Interest Margin 1.54% Vs. 1.56% in 1H>ANZ.AU

9 nov. 2025, 20:49 UTC

Résultats

ANZ FY Australia Retail Deposits Up 6% on Year>ANZ.AU

9 nov. 2025, 20:49 UTC

Résultats

ANZ FY Australia Home Loan Lending Up 5% on Year>ANZ.AU

9 nov. 2025, 20:45 UTC

Résultats

ANZ FY Average Customer Deposits A$760.8B Vs. A$669.4B>ANZ.AU

9 nov. 2025, 20:45 UTC

Résultats

ANZ FY Average Gross Loans & Advances A$833.6B Vs. A$733.8B>ANZ.AU

9 nov. 2025, 20:42 UTC

Résultats

ANZ FY Results Include Full-Year Benefit of Suncorp Bank Acquisition>ANZ.AU

9 nov. 2025, 20:42 UTC

Résultats

ANZ FY Net Interest Margin 1.55% Vs. 1.57%>ANZ.AU

9 nov. 2025, 20:41 UTC

Résultats

ANZ FY Common Equity Tier 1 Ratio 12.0% Vs. 12.2%>ANZ.AU

9 nov. 2025, 20:41 UTC

Résultats

ANZ FY Net Profit Includes A$1.11B of Notable Items>ANZ.AU

9 nov. 2025, 20:39 UTC

Résultats

ANZ FY Credit Impairment Charge A$441M Vs. A$406M>ANZ.AU

9 nov. 2025, 20:39 UTC

Résultats

ANZ FY Rev A$22.19B Vs. A$20.55B >ANZ.AU

9 nov. 2025, 20:38 UTC

Résultats

ANZ Keeps Dividend at A$0.83 >ANZ.AU

9 nov. 2025, 20:38 UTC

Résultats

ANZ FY Cash Profit A$5.79B Vs. A$6.725B>ANZ.AU

9 nov. 2025, 20:38 UTC

Résultats

ANZ FY Net A$5.89B Vs. Net A$6.535B >ANZ.AU

8 nov. 2025, 13:10 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov. 2025, 03:50 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov. 2025, 03:41 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov. 2025, 03:07 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov. 2025, 22:36 UTC

Résultats

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 nov. 2025, 22:22 UTC

Résultats

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q Rev $2.95B >CSU.T

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q Net $210M >CSU.T

7 nov. 2025, 22:03 UTC

Résultats

Constellation Software 3Q EPS $9.89 >CSU.T

Comparaison

Variation de prix

Aytu BioScience Inc prévision

Objectif de Prix

By TipRanks

351.72% hausse

Prévisions sur 12 Mois

Moyen 9.17 USD  351.72%

Haut 12.5 USD

Bas 7 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

3

Achat

0

Maintien

0

Vente

Éléments financiers

$

help-icon Live chat